Unusual cytotoxicities of 5-(acylethynyl)-1-(2- hydroxyethoxy)methyluracils

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 13, 1996, Pages 1497-1502

  Kundu, Nitya G ^a   Mahanty, Jyan S ^a   Spears, C Paul ^b  

^a DEPARTMENT OF MATERIALS SCIENCE   (India)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ACETOXYETHOXY)METHYL 5 IODOURACIL; 1 (2 HYDROXYETHOXY)METHYL 5 (4 METHOXYBENZOYLETHYNYL)URACIL; 1 (2 HYDROXYETHOXY)METHYL 5 (4 TOLUOYLETHYNYL)URACIL; 1 (2 HYDROXYETHOXY)METHYL 5 FLUOROURACIL; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; COLON CARCINOMA; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOUSE; MURINE LEUKEMIA; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MURINAE;

EID: 0030576317     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00256-9     Document Type: Article

References (26)

1. 1. Part 22 of our series on Studies on Uracil Derivatives and Analogues; for Part 21 see : Kundu, N.G.; Mahanty, J.S.; Spears, C.P.; Andrei, G.; Snoeck, R.; Balzarini, J.; De Clercq, E. Bioorg. Med. Chem. Lett. 1995, 5, 1627.
2. 2. Heidelberger, C. Pyrimidine and Pyrimidine Antimetabolites in Cancer Medicine; Holland, J.F.; Frei, E., Eds; Lea and Febiger : Philadelphia 1984, pp. 801-824.
3. 3. Kundu, N.G.; Das, B.; Spears, C.P.; Majumdar, A.; Kang, S.-I. J. Med. Chem. 1990, 33, 1975.
4. 4. Kundu, N.G.; Dasgupta, S.K.; Chaudhuri, L.N.; Mahanty, J.S.; Spears, C.P.; Shahinian, A.H. Eur. J. Med. Chem. 1993, 28, 473.
5. 5. Kundu, N.G.; Dasgupta, S.K. J. Chem. Soc. Perkin Trans, I 1993, 2657.
6. 50's were found to be 6-12 μM.
7. 7. Elion, G.B.; Furman, P.A.; Fyfe, J.A.; de Miranda, P.; Beauchamp, L.; Schaeffer, H.J. Proc. Natl. Acad. Sci. USA 1977, 74, 5716.
8. 8. Dolin, R. Science 1985, 227, 1296.
9. 9. Miyasaka, T.; Tanaka, H.; Baba, M.; Hayakawa, H.; Walker, R.T.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1989, 32, 2507.
10. 10. Tanaka, H.; Baba, M.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R.T.; De Clercq, E.; Miyasaka, T. J. Med. Chem. 1991, 34, 1394.
11. 11. Baba, M.; De Clercq, E.; Tanaka, H.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Umezu, K.; Nakashima, H.; Mori, S.; Shigeta, S.; Walker, R.T.; Miyasaka, T. Proc. Natl. Acad. Sci. USA 1991, 88, 2356.
12. 12. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R.T.; De Clercq, E.; Miyasaka, T. J. Med. Chem. 1992, 35, 337.
13. 13. De Clercq, E. Med. Res. Rev. 1993, 13, 229.
14. 14. Drewes, S.E.; Douglass, D.; Malissar, D.G.S.; Roos, G.H.P.; Kaye, P.T. J. Chem. Soc. Perkin Trans. I 1990, 1507 and references cited therein.
15. 15. Robins, M.J.; Hatfield, P.W. Can. J. Chem. 1982, 60, 547.
16. 16. Rosowsky, A.; Kim, S.-H.; Wick, M. J. Med. Chem. 1981, 24, 1177.
17. 17. Niedballa, U.; Vorbrüggen, J. Org. Chem. 1974, 39, 3654.
18. 18. Jones, E.R.H.; McCombie, J.T. J. Chem. Soc. 1942, 733; Campbell, K.N.; Campbell, B.K.; Eby, L.T.J. J. Am. Chem. Soc. 1938, 60, 2882.
19. 18. Jones, E.R.H.; McCombie, J.T. J. Chem. Soc. 1942, 733; Campbell, K.N.; Campbell, B.K.; Eby, L.T.J. J. Am. Chem. Soc. 1938, 60, 2882.
20. 7 : C, 59.06; H, 4.70; N, 7.25 found : C, 59.22; H, 4.69; N, 7.01.
21. 6 : C, 59.30; H, 4.68; N, 8.14 found : C, 59.68; H, 4.51; N, 8.15.
22. 21. Kang, S.-I.; Spears, C.P. J. Med. Chem. 1987, 30, 597.
23. 22. Rosowsky, A.; Kim, S.-H.; Wick, M. J. Med. Chem. 1981, 24, 1177.
24. 23. Schroeder, A.C.; Hughes Jr, R.G.; Bloch, A. J. Med. Chem. 1981, 24, 1078.
25. 24. Kelley, J.L.; Kelsey, J.E.; Hall, W.R.; Krochmal, M.P.; Schaeffer, H.J. J. Med. Chem. 1981, 24, 753.
26. 25. Robins, M.J.; Hatfield, P.W.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1984, 27, 1486.